9^th World Congress on Chromatography May 13-14, 2019 Paris, France

V. A. Krylov, Doctor of Chemistry, Professor, Head of the Division of Analytical Chemistry of the Nizhny Novgorod State University. The main direction of scientific research of professor Krylov is the development of the theory and applications of chromatography for the analysis of high purity substances, environmental objects and development of methods of the microextraction. The attained detection limits for impurities constitute 10–6 to 10–11 wt % and hit a record low. He is the author of more than 200 scientific papers, including reviews on the analytical chemistry of high purity volatile substances, air and liquid-liquid microextraction preconcentration.

applications of chromatography for the analysis of high purity substances

Raafat A Mandour is awarded PhD in Hydrogeochemistry in 2004. He holds a Master Degree (MSc) in Hydrogeochemistry in 2001. He is an International member of the editorial advisory board of Universal Journal of Environmental Research and Technology (UJERT). His research interests reflect in his wide range of publications in 10 national and 13 international journals.

Medicinal Chemistry, Semen quality parameters, Semen flow-cytometry analysis, drinking water pollution

Dr. Ch. Gangu Naidu, Asst. professor of Chemistry, S&H, has expertise in evaluation and passion in improving the novel method development and validations by using modern spectroscopic techniques. Previously, i carried out my M.Sc. and Ph.D. programme at dep. of Chemistry, Andhra University, Visakhapatnam. After my doctoral research (2014), I do have a short stint of industrial experience, worked as an Executive at Mylan Laboratories, Hyderabad and senior research associate (SRA) at Diacel Chiral Technologies, pvt. Laboratories, IKP Knowledge park, Hyderabad (Nov-2014 to Nov-2015), Andhra Pradesh, India. I have experience in various research fields of analytical Chemistry (LC and LC-MS/MS Method development and validation of novel analytical and bioanalytical applications of active pharmaceutical ingradients (API’s.) during my doctoral and SRA tenure i published 21 peer reviewed research papers with a cumulative impact factor of 44.71 (h index: 7, i10 index: 6) Project work carried out 40 dissertation M.Sc students.

Supported liquid extraction and LC-MS/MS determination of iloperidone and olanzapine in rat plasma

Shaorong Liu, Director of the Center for Bioanalysis and Professor in the Department of Chemistry and Biochemistry at University of Oklahoma in Norman, Oklahoma, USA. Dr. Liu’s group is focused on developing enabling technologies for biotech research, and more specifically miniaturized analytical systems for ultra-high speed and ultra-high resolution separations of biomolecules. The miniaturized systems include capillary-based apparatus, microchip-based devices instruments and capillary-microchip hybrid devices, while the biomolecules consist of DNA, protein, peptides, steroids and other small molecules. Recently in Dr. Liu’s lab, they have demonstrated a record-high resolution for separating an enzyme-digested E. coli lysate and obtained a peak capacity of close to 1800 in 3-h gradient time using a narrow open tubular (NOT) column. Using a short NOT column, they have also demonstrated sub-second separation of 6 amino acids; all six amino acids were resolved within less than 500 milliseconds. He is the author of more than 120 scientific papers, and inventor of seven patents.

Chemistry and Biochemistry

Meliha Ekinci completed with the highest GPA her bachelor’s degree at Ege University, Turkey in 2013 and she obtained her master’s degree in Radiopharmacy at Ege University, Turkey in 2015. She is currently a PhD candidate and also a research assistant at Radiopharmacy Department, Ege University, Turkey.She has completed 6 scientific research projects and she is currently working on 2 projects about new radiopharmaceuticals. She is doctoral scholarship student of Turkish Scientific and Technological Research Center (TUBITAK) (Granted code: TUBITAK 2211-A 01.10.2015 – Ongoing). She is a member of professional societies like European Federation of Pharmaceutical Science (EUFEPS) and Society of Radiopharmaceutical Sciences (SRS) and local societies.

Radiopharmaceuticals, Cancer diagnosis, Breast cancer, Nanotechnology, Novel drug delivery systems.

Dr. Xue obtained her M.D. from the Shanghai Second Military Medical University in 1983, Ph.D. from the Institute of medical Sciences and Department of Biochemistry, University of Toronto in 1992, and carried out postdoctoral studies at the Department of Genetics, University of Glasgow before joining the Department of Biochemistry, Hong Kong University of Science & Technology (HKUST). Currently, Dr. Xue is Director of Applied Genomics Center of HKUST, and Professor of Life Science at Hong Kong University of Science and Technology. Dr. Xue’s group research focuses on genomics, bioinformatics and evolution biology to decipher the mechanisms of human complex diseases, in particular, schizophrenia. The group is also interested in translational research on novel therapeutics and diagnostics for complex neuropsychiatric disorders including anxiety, depression and neurodegenerative disorders, with a focus on GABAA receptors as the drug targets. In order to effectively isolate active components from medicinal herbs, her group has recently developed a novel chromatographic method designated as Disbursed Mobile-Phase Countercurrent Chromatography (DMCC). In 2003, Dr. Xue and her team discovered the association between schizophrenia and a segment of the GABRB2 gene encoding the -subunit of GABAA receptors, the positive selection of genotypes and haplotypes in this segment, determinant role of this segment in the alternate splicing of the subunit protein, and the differential modulation of the GABA-induced membrane current by the long and short forms. These discoveries represent therefore the first instance where a schizophrenia-susceptibility gene has been linked to protein processing and further to electrophysiological response of neurons, thereby opening the door toward understanding the mechanism of schizophrenia etiology leading from gene to neuronal phenotype.

Genomics, Bioinformatics and Evolution biology